Session date: 
06/01/2016 - 12:15pm to 1:15pm

Bernard J. Gersh, M.B.. Ch.B.; D.Phil, F.R.C.P., M.A.C.C.  
Professor of Medicine, Mayo Clinic College of Medicine
Recipient, 2012 James B. Herrick Award
Recipient, 2015 Mayo Clinic Distinguished Alumni Award
Will receive the Gold Medal of the ESC in August 2016

Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and MA 17-64
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis


Learning Objectives:

  • Describe the concept that atrial fibrillation is a vascular disease
  • Describe the strength and limitations of current algorithms for risk stratification for stroke and systemic thromboembolism
  • Discus the aspects of management of device-detected clinically silent atrial fibrillation
  • Describe the advantages and limitations of the novel oral anticoagulants in comparison to warfarin

Financial Disclosure:

  • None

Off Label/Investigational Uses:

  • None

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota